Agios Pharmaceuticals資訊中心

Leerink Partners維持Agios Pharmaceuticals(AGIO.US)持有評級

moomoo資訊11/12 03:31 (美東)

agios pharmaceuticals被Scotiabank維持在板塊表現評級

道瓊斯11/01 10:31 (美東)

美銀證券維持Agios Pharmaceuticals(AGIO.US)買入評級

moomoo資訊11/01 10:31 (美東)

豐業銀行維持Agios Pharmaceuticals(AGIO.US)買入評級，上調目標價至53美元

moomoo資訊11/01 08:31 (美東)

加皇資本市場維持Agios Pharmaceuticals(AGIO.US)買入評級，維持目標價55美元

moomoo資訊11/01 06:36 (美東)

TD Cowen維持Agios Pharmaceuticals(AGIO.US)買入評級

moomoo資訊10/31 15:31 (美東)

派傑投資維持Agios Pharmaceuticals(AGIO.US)買入評級，維持目標價56美元

moomoo資訊10/23 08:35 (美東)

Scotiabank宣佈agios pharmaceuticals股票的目標價格爲51.00美元/股。

道瓊斯10/16 10:35 (美東)

Leerink Partners維持Agios Pharmaceuticals(AGIO.US)持有評級

moomoo資訊10/15 03:32 (美東)

瑞傑金融上調Agios Pharmaceuticals(AGIO.US)至買入評級，目標價51美元

moomoo資訊10/10 09:31 (美東)

agios pharmaceuticals分析師評級

Benzinga10/10 08:56 (美東)

agios pharmaceuticals被雷蒙德詹姆斯評爲表現優異

TipRanks10/10 08:33 (美東)

Leerink Partners維持Agios Pharmaceuticals(AGIO.US)持有評級，維持目標價56美元

moomoo資訊10/01 01:33 (美東)

Leerink Partners下調Agios Pharmaceuticals(AGIO.US)至持有評級，下調目標價至56美元

moomoo資訊09/27 06:31 (美東)

Agios Pharmaceuticals在Leerink的評級由Outperform下調至Market Perform

TipRanks09/27 06:17 (美東)

美銀證券維持Agios Pharmaceuticals(AGIO.US)買入評級，上調目標價至57美元

moomoo資訊09/27 05:32 (美東)

派傑投資維持Agios Pharmaceuticals(AGIO.US)買入評級，維持目標價56美元

moomoo資訊09/26 14:32 (美東)

agios pharmaceuticals分析師評級

Benzinga09/19 09:08 (美東)

加皇資本市場維持Agios Pharmaceuticals(AGIO.US)買入評級，維持目標價55美元

moomoo資訊09/19 07:33 (美東)

派傑投資維持Agios Pharmaceuticals(AGIO.US)買入評級，維持目標價56美元

moomoo資訊09/10 14:32 (美東)